Expertise in
7
conditions

Aristotelis Bamias

Athens, ESYE31, GR 
Expertise in
7
conditions
Athens, ESYE31, GR 
OverviewLocationsClinical Research

Overview

Aristotelis Bamias practices in Athens, Greece. Mr. Bamias is highly rated in 7 conditions, according to our data. His top areas of expertise are Urothelial Cancer, Renal Cell Carcinoma (RCC), Ovarian Cancer, Cystectomy, and Nephrectomy.

His clinical research consists of co-authoring 184 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Athens, ESYE31, Greece
Other Locations
Marousi, ESYE31, Greece
Evrou St 89, Attiki, ESYE31 11527, Greece
Chaidari, ESYE31 12462, Greece

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 26, 2024
Intervention Type: Drug
Study Phase: Phase 3
Randomized ph. II Study to Explore Efficacy and Feasibility of Upfront Rotations Between SUNitinib and Everolimus vs Sequential Treatment of 1st lIne Sunitinib & 2nd Line EverolimuS Until Progression in Pats Met. Clear Cell Renal Cancer
Randomized ph. II Study to Explore Efficacy and Feasibility of Upfront Rotations Between SUNitinib and Everolimus vs Sequential Treatment of 1st lIne Sunitinib & 2nd Line EverolimuS Until Progression in Pats Met. Clear Cell Renal Cancer
Enrollment Status: Terminated
Publish Date: October 02, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

184 Total Publications

Healthcare resource utilization and associated costs in patients with metastatic castration-resistant prostate cancer in Greece.
Healthcare resource utilization and associated costs in patients with metastatic castration-resistant prostate cancer in Greece.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: May 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bamias's expertise for a condition
ConditionClose
View All 25 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile